Our research is focused at the intersection of quantitative imaging and targeted therapeutics. Utilizing advanced model systems of disease with noninvasive measures of treatment response, we seek to develop and optimize treatments to inform patient management and to improve outcomes.

We apply a modality-agnostic approach, with a strong emphasis on physical and computational methods. The questions we ask are intended to reveal or overcome persistent challenges in the field of cancer treatment and infectious disease characterization, with a collaborative team-science approach. See our Publications for some of our recent multidisciplinary work.